MedTrace Logo

Cognitive Behavioral Therapy for Insomnia (CBTi) in Patients With Comorbid Somatic Disease and Insomnia

NCT04598672 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2026-04-30

No results posted yet for this study

Summary

Insomnia is common with co-morbid somatic disease, e.g. rheumatic disease, cancer, heart and lung disease or gastrointestinal disorders. Pain, breathing difficulties and other symptoms of disease can worsen sleep problems and cause insomnia. In turn, insomnia may aggravate pain, fatigue and reduce quality of life in patients with somatic disorders. This project aims to evaluate a course offered to patients with insomnia and somatic disease at Diakonhjemmet Hospital. The course is based on cognitive behavioral therapy, a documented treatment for insomnia.

Conditions

  • Insomnia
  • Insomnia Chronic
  • Sleep Initiation and Maintenance Disorders
  • Sleep Disorder
  • Sleep Disturbance
  • Chronic Disease
  • Insomnia Due to Medical Condition
  • Insomnia, Psychophysiological

Interventions

BEHAVIORAL

Cognitive behavioral therapy for insomnia (CBTi)

Patients will undergo a 7 sessions course in cognitive behavioral therapy for insomnia.

Sponsors & Collaborators

  • Diakonhjemmet Hospital

    lead OTHER

Principal Investigators

  • Kåre Osnes, M.D., Ph.D. · Department of Psychiatry, Diakonhjemmet Hospital, Oslo, Norway

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2022-12-31
Completion
2025-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04598672 on ClinicalTrials.gov